From ESH 2016 | LB 3: Davide Agnoletti, MD

Slides:



Advertisements
Similar presentations
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
Advertisements

Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
An analysis of 22,672 patients from the CLARIFY registry
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Torbjørn Omland, MD, PHD, MPH, Marc S.
ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy From ESH 2016 | LB 1: Jean-Pierre Fauvel, MD CHU Lyon, Hôpital E Herriot,
Volume 82, Issue 12, Pages (December 2012)
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
The Plasma Concentrations of Atorvastatin and its Active Metabolites in Relation to the Dose in Stable Coronary Artery Disease Patients at a Tertiary Referral.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Ungroup once.
Copyright © 2014 American Medical Association. All rights reserved.
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
Baseline characteristics and effectiveness results
From ESH 2016 | POS 7D: Jan Rosa, MD
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Elevated Circulating Levels of Inflammatory Markers in
All-cause mortality by treatment group
From ESH 2016 | POS 3C: Luiz Aparecido Bortolotto, MD, PhD
BEAUTY Trial: Hypertension Control Not Improved with Hemodynamic Monitoring From ESH 2016 | LB 3: Pierre Boutouyrie, MD, PhD INSERM, Université Paris Descartes,
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Copyright © 2007 American Medical Association. All rights reserved.
The Anglo Scandinavian Cardiac Outcomes Trial
ELIGIBILITY: MRC/BHF Heart Protection Study
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Copyright © 2012 American Medical Association. All rights reserved.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
The percentage of subjects with de novo development of renal function impairment (GFR
Progress and Promise in RAAS Blockade
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Baseline characteristics of HPS participants by prior diabetes
The Hypertension in the Very Elderly Trial (HYVET)
The results of the SHARP trial
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Volume 93, Issue 4, Pages (April 2018)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Dileep Raman et al. JACEP 2017;3:
Description of studies for pooled analyses
The Diabetes Cross-Disciplinary Index (DXDI).
Volume 82, Issue 12, Pages (December 2012)
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Lipid-Lowering Arm (ASCOT-LLA): Results in the Subgroup of Patients with Diabetes Peter S. Sever, Bjorn Dahlöf, Neil Poulter, Hans Wedel, for the.
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy  Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
The following slides are from a Cardiology Scientific Update in which Dr. Gordon Moe reported and discussed an original presentation by Drs. Bjorn Dahlof,
THE ELDERLY POPULATION
These slides highlight a report from a Hotline Session and a Satellite symposium held at the European Society of Cardiology Congress, 2003 in Vienna Austria,
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
RECORD Study: Enrollment and Outcomes
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
The results of the SHARP trial
PROSPER: trial design                                                                                                                                                                 
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
A – Demographic, Anthropometric and Clinical correlates of plasma NT-proBNP levels stratified by race: Multivariable Regression Results (Multivariable.
Presentation transcript:

Arterial Stiffness and Diastolic Dysfunction Explored in Relation to Diabetes From ESH 2016 | LB 3: Davide Agnoletti, MD Sacro Cuore Hospital, Verona, Italy

Study Population Relation between diastolic function and arterial hemodynamics in diabetic and nondiabetic hypertension investigated 123 patients screened for primary or secondary cardiovascular (CV) prevention at Paris hospital; ≥1 CV risk factor Hemodynamics measured centrally by tonometry and peripherally, diastolic function by echocardiography Patients with diabetes older, more were smokers and metabolic syndrome, but better lipid control Diabetic hypertension more commonly treated with angiotensin- receptor blockers, less likely with calcium channel blockers

Baseline Characteristics Variables NO DIAB (n=79) DIAB (n=44) Mean (SD) P value Age, years 56(14) 64(9) 0.0028 Male gender, n (%) 39(49) 28(64) 0.1277 Weight, kg 78(15) 80(14) 0.457 Height, cm 168(9) 168(8) 0.8058 Body mass index, kg/m2 28(5) 28(4) 0.5132 Waist circumference, mm 94(13) 100(11) 0.0073 Total cholesterol, mmol/L 4.79(1.02) 4.08(1.02) 0.0004 HDL cholesterol, mmol/L 1.38(0.41) 1.22(0.42) 0.0513 Triglycerides, mmol/L 1.20(0.77) 1.41(0.79) 0.1647 LDL cholesterol, mmol/L 2.88(0.84) 2.24(0.83) 0.0001 Creatinine, µmol/L 84(21) 90(25) 0.1185 eGFR, mL/min 81(20) 76(20) 0.2229 DIAB, diabetes; eGFR, estimated glomerular filtration rate.

Baseline Characteristics Variables NO DIAB (n=79) DIAB (n=44) N (%) P value Smoking 35(44) 28(64) 0.0398 Hypertension 71(90) 38(86) 0.5569 Familiarity for CHD 5(6) 5(11) 0.3274 Stroke 4(5) 3(7) 0.6872 CHD 6(8) 6(14) 0.2411 Myocardial infarction 3(4) 4(9) 0.2245 Revascularization 0.1734 Peripheral artery disease 2(3) 0.0969 Metabolic Syndrome 17(22) <.0001 DIAB, diabetes; CHD, coronary heart disease.

Results Similar central and peripheral blood pressure levels in patients with hypertension with and without diabetes Carotid-femoral pulse wave velocity significantly higher in diabetic hypertension Augmentation index and pulse pressure amplification similar regardless of diabetes status Diastolic and systolic function similar regardless of diabetes status

Hemodynamic Outcomes By Diabetic Status Hemodynamics: *p<0.05 AIx, augmentation index; cf-PWV, carotid-femoral pulse wave velocity; DIAB, diabetes; PPA, pulse pressure amplification.

Results Pulse wave velocity and E/E’ ratio positively and significantly related in total population (r=0.199; p=0.027) No difference by diabetes status after adjustment for age, sex, mean arterial pressure, heart rate Pulse pressure amplification and the E/E’ ratio negatively and significantly related in total population (r=0.172; p=0.057) and in diabetic hypertension (r=0.352; p=0.019) Determinant of pulse pressure amplification differ by diabetic status Diabetes: use of blockers of renin angiotensin system, E/E’ ratio No diabetes: family history of coronary heart disease, mean arterial pressure

Conclusion Positive relation between arterial stiffness and diastolic dysfunction found in total study population of patients with hypertension with and without diabetes In diabetic hypertension, pulse pressure amplification inversely related to diastolic dysfunction 14% of the variance in pulse pressure amplification due to E/E’ ratio

Arterial Stiffness and Diastolic Dysfunction Explored in Relation to Diabetes From ESH 2016 | LB 3: Davide Agnoletti, MD Sacro Cuore Hospital, Verona, Italy